药石科技
(300725)
| 流通市值：77.01亿 | | | 总市值：88.82亿 |
| 流通股本：2.03亿 | | | 总股本：2.34亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,419,054,885.82 | 919,729,079.06 | 455,018,107.75 | 1,688,619,647.07 |
| 营业收入 | 1,419,054,885.82 | 919,729,079.06 | 455,018,107.75 | 1,688,619,647.07 |
| 二、营业总成本 | 1,281,579,226.63 | 829,705,605.73 | 412,531,258.48 | 1,441,959,716.75 |
| 营业成本 | 979,876,477.06 | 634,187,513.17 | 316,982,758.01 | 1,046,009,643.66 |
| 税金及附加 | 18,500,941.28 | 11,317,519.75 | 5,719,304.58 | 21,849,648 |
| 销售费用 | 46,561,981.64 | 30,891,836 | 15,143,093.02 | 57,304,723.22 |
| 管理费用 | 131,963,054.07 | 86,287,364.87 | 42,402,305.63 | 181,167,547.26 |
| 研发费用 | 79,045,014.56 | 48,352,749.39 | 21,559,149.46 | 107,330,053.84 |
| 财务费用 | 25,631,758.02 | 18,668,622.55 | 10,724,647.78 | 28,298,100.77 |
| 其中:利息费用 | 36,518,069.43 | 26,659,424.42 | 13,692,073.93 | 60,910,195.57 |
| 其中:利息收入 | 9,857,791.51 | 8,306,009.58 | 3,527,610.58 | 10,326,781.47 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,886,235.72 | -434,704.1 | -1,137,994.59 | 9,360,884.19 |
| 加:投资收益 | 21,642,740.8 | 11,059,877.09 | 4,356,576.46 | 35,436,886.52 |
| 资产减值损失(新) | -52,886,799.16 | -35,171,242.71 | -18,498,451.08 | -60,310,848.33 |
| 信用减值损失(新) | 6,017,450.03 | 10,199,575.32 | 6,243,874.59 | -5,492,532.66 |
| 其他收益 | 16,262,839.51 | 11,692,255.91 | 4,709,741.81 | 25,550,658.55 |
| 四、营业利润 | 130,398,126.09 | 87,369,234.84 | 38,160,596.46 | 251,204,978.59 |
| 加:营业外收入 | 433,649.28 | 186,690.63 | 137,509.09 | 428,349.9 |
| 减:营业外支出 | 2,597,611.53 | 1,284,663.14 | 358,770.53 | 2,737,450.77 |
| 五、利润总额 | 128,234,163.84 | 86,271,262.33 | 37,939,335.02 | 248,895,877.72 |
| 减:所得税费用 | 14,843,532.57 | 13,773,163.21 | 2,148,584.06 | 29,356,043.84 |
| 六、净利润 | 113,390,631.27 | 72,498,099.12 | 35,790,750.96 | 219,539,833.88 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 113,390,631.27 | 72,498,099.12 | 35,790,750.96 | 219,539,833.88 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 113,390,631.27 | 72,498,099.12 | 35,790,750.96 | 219,539,833.88 |
| 扣除非经常损益后的净利润 | 88,157,340.26 | 59,621,052.27 | 30,537,131.92 | 173,124,567.76 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.56 | 0.36 | 0.18 | 1.1 |
| (二)稀释每股收益 | 0.56 | 0.36 | 0.18 | 1.1 |
| 八、其他综合收益 | 2,945,282,499.54 | 620,307,975.98 | -152,770.58 | 1,529,074.58 |
| 归属于母公司股东的其他综合收益 | 2,945,282,499.54 | 620,307,975.98 | -152,770.58 | 1,529,074.58 |
| 九、综合收益总额 | 3,058,673,130.81 | 692,806,075.1 | 35,637,980.38 | 221,068,908.46 |
| 归属于母公司股东的综合收益总额 | 3,058,673,130.81 | 692,806,075.1 | 35,637,980.38 | 221,068,908.46 |
| 公告日期 | 2025-10-30 | 2025-08-08 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |